HHS Extends PREP Act To Pharmacists Administering COVID-19 Therapies

By Beth Wang / September 10, 2021 at 1:23 PM
Licensed pharmacists, qualified pharmacy technicians and pharmacy interns can now administer FDA-authorized COVID-19 therapies, including monoclonal antibodies, while being protected from liability under the Public Readiness and Emergency Preparedness Act, HHS announced Thursday (Sept. 9). HHS issued the PREP Act expansion Thursday as part of the Biden administration’s broader six-point plan to combat the COVID-19 pandemic . Biden’s plan aims to expand the number of providers who can administer COVID-19 monoclonal antibodies. Under Biden’s plan, so-called federal monoclonal antibody strike...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.